Suvorexant Cuts Tau Phosphorylation and Amyloid-β Concentrations

FRIDAY, April 28, 2023 -- The insomnia drug suvorexant acutely decreases tau phosphorylation and amyloid-β concentrations in the central nervous system, according to a study published online April 20 in the Annals of Neurology.
Brendan P. Lucey,...